Physician profile
John Poche
NPI 1386222800
$3,671.07
in general payments reported to CMS, 2019-2025
7 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.75 · 2023: $351 · 2024: $428 · 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,112 · Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,112.06 |
| Food and Beverage | $1,513.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,464.18 | 2023-2025 | Na, Scopis Ent, Xpress Ent Dilation System |
| Medtronic, INC. | $668.66 | 2022-2025 | Stealthstation S8 Platform, Pteye Parathyroid Detection System, Propel |
| Regeneron Healthcare Solutions, INC. | $219.45 | 2024-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $139.17 | 2024-2025 | |
| Inspire Medical Systems, INC. | $84.99 | 2024-2025 | Inspire |
| Aerin Medical INC. | $71.41 | 2025 | |
| Atos Medical INC | $23.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Poche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.